SLC35F2

Across TCGA pan-cancer cohorts, SLC35F2 mass-spec protein differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of SLC35F2’s most consistent transcriptional readouts.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where SLC35F2 mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types SLC35F2 is over-expressed in tumor, although a few such as CCRCC show the opposite, repressed pattern.

CCRCC and HNSC are the cancer types where SLC35F2 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SLC35F2 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
CCRCC	Female	All	−0.733	<.001	7	view →
HNSC	All	III,IV	+0.324	.011	6	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

SLC35F2–CCRCC

Open the CCRCC breakdown →